vs

Side-by-side financial comparison of CORE MOLDING TECHNOLOGIES INC (CMT) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

CORE MOLDING TECHNOLOGIES INC is the larger business by last-quarter revenue ($74.7M vs $44.6M, roughly 1.7× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). On growth, CORE MOLDING TECHNOLOGIES INC posted the faster year-over-year revenue change (19.5% vs 13.8%). CORE MOLDING TECHNOLOGIES INC produced more free cash flow last quarter ($-2.9M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -2.2%).

Core Molding Technologies, Inc. was founded in 1988 and now based in Columbus, Ohio. The company manufactures sheet molding compounds (SMC), and molds fiberglass reinforced plastics. It occupies over 1,000,000 square feet of manufacturing space and its main subsidiaries are in Matamoros, Mexico, Gaffney, South Carolina, and Cincinnati, Ohio. In 2011, Core Molding Technologies formed Core Specialty Composites, LLC.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

CMT vs PACB — Head-to-Head

Bigger by revenue
CMT
CMT
1.7× larger
CMT
$74.7M
$44.6M
PACB
Growing faster (revenue YoY)
CMT
CMT
+5.7% gap
CMT
19.5%
13.8%
PACB
More free cash flow
CMT
CMT
$17.0M more FCF
CMT
$-2.9M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-2.2%
CMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMT
CMT
PACB
PACB
Revenue
$74.7M
$44.6M
Net Profit
$-40.4M
Gross Margin
15.2%
37.1%
Operating Margin
4.8%
-92.3%
Net Margin
-90.4%
Revenue YoY
19.5%
13.8%
Net Profit YoY
-1802.7%
EPS (diluted)
$0.35
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMT
CMT
PACB
PACB
Q4 25
$74.7M
$44.6M
Q3 25
$58.4M
$38.4M
Q2 25
$79.2M
$39.8M
Q1 25
$61.4M
$37.2M
Q4 24
$62.5M
$39.2M
Q3 24
$73.0M
$40.0M
Q2 24
$88.7M
$36.0M
Q1 24
$78.1M
$38.8M
Net Profit
CMT
CMT
PACB
PACB
Q4 25
$-40.4M
Q3 25
$1.9M
$-38.0M
Q2 25
$4.1M
$-41.9M
Q1 25
$2.2M
$-426.1M
Q4 24
$2.4M
Q3 24
$3.2M
$-60.7M
Q2 24
$6.4M
$-173.3M
Q1 24
$3.8M
$-78.2M
Gross Margin
CMT
CMT
PACB
PACB
Q4 25
15.2%
37.1%
Q3 25
17.4%
41.4%
Q2 25
18.1%
36.9%
Q1 25
19.2%
-3.7%
Q4 24
15.8%
25.6%
Q3 24
16.9%
25.0%
Q2 24
20.0%
16.5%
Q1 24
17.0%
29.1%
Operating Margin
CMT
CMT
PACB
PACB
Q4 25
4.8%
-92.3%
Q3 25
4.4%
-101.1%
Q2 25
6.6%
-112.8%
Q1 25
4.6%
-1154.5%
Q4 24
1.4%
-390.1%
Q3 24
4.9%
-160.3%
Q2 24
8.4%
-488.3%
Q1 24
6.1%
-209.6%
Net Margin
CMT
CMT
PACB
PACB
Q4 25
-90.4%
Q3 25
3.2%
-98.9%
Q2 25
5.1%
-105.4%
Q1 25
3.6%
-1146.8%
Q4 24
6.0%
Q3 24
4.3%
-151.9%
Q2 24
7.2%
-481.3%
Q1 24
4.8%
-201.4%
EPS (diluted)
CMT
CMT
PACB
PACB
Q4 25
$0.35
$-0.11
Q3 25
$0.22
$-0.13
Q2 25
$0.47
$-0.14
Q1 25
$0.25
$-1.44
Q4 24
$-0.01
$-0.44
Q3 24
$0.36
$-0.22
Q2 24
$0.73
$-0.64
Q1 24
$0.43
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMT
CMT
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$38.1M
$279.5M
Total DebtLower is stronger
$17.6M
Stockholders' EquityBook value
$158.2M
$5.3M
Total Assets
$228.1M
$784.1M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMT
CMT
PACB
PACB
Q4 25
$38.1M
$279.5M
Q3 25
$42.4M
$298.7M
Q2 25
$43.2M
$314.7M
Q1 25
$44.5M
$343.1M
Q4 24
$41.8M
$389.9M
Q3 24
$42.3M
$471.1M
Q2 24
$37.8M
$509.8M
Q1 24
$26.6M
$561.9M
Total Debt
CMT
CMT
PACB
PACB
Q4 25
$17.6M
Q3 25
$18.2M
Q2 25
$18.8M
Q1 25
$19.2M
Q4 24
$19.7M
Q3 24
$20.2M
Q2 24
$20.6M
Q1 24
$21.1M
Stockholders' Equity
CMT
CMT
PACB
PACB
Q4 25
$158.2M
$5.3M
Q3 25
$155.4M
$36.1M
Q2 25
$153.5M
$61.5M
Q1 25
$149.9M
$91.6M
Q4 24
$147.4M
$506.6M
Q3 24
$147.8M
$453.1M
Q2 24
$147.5M
$492.7M
Q1 24
$142.8M
$649.0M
Total Assets
CMT
CMT
PACB
PACB
Q4 25
$228.1M
$784.1M
Q3 25
$219.7M
$803.2M
Q2 25
$219.9M
$825.5M
Q1 25
$223.6M
$860.8M
Q4 24
$209.6M
$1.3B
Q3 24
$220.7M
$1.5B
Q2 24
$225.7M
$1.5B
Q1 24
$212.3M
$1.7B
Debt / Equity
CMT
CMT
PACB
PACB
Q4 25
0.11×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.14×
Q2 24
0.14×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMT
CMT
PACB
PACB
Operating Cash FlowLast quarter
$5.0M
$-19.1M
Free Cash FlowOCF − Capex
$-2.9M
$-19.9M
FCF MarginFCF / Revenue
-3.9%
-44.6%
Capex IntensityCapex / Revenue
10.7%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.9M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMT
CMT
PACB
PACB
Q4 25
$5.0M
$-19.1M
Q3 25
$4.6M
$-18.7M
Q2 25
$3.5M
$-29.4M
Q1 25
$6.1M
$-44.1M
Q4 24
$5.0M
$-30.6M
Q3 24
$9.2M
$-45.5M
Q2 24
$15.9M
$-54.3M
Q1 24
$5.1M
$-75.7M
Free Cash Flow
CMT
CMT
PACB
PACB
Q4 25
$-2.9M
$-19.9M
Q3 25
$-346.0K
$-18.8M
Q2 25
$880.0K
$-29.9M
Q1 25
$4.3M
$-45.4M
Q4 24
$509.0K
$-32.3M
Q3 24
$7.0M
$-46.3M
Q2 24
$13.0M
$-55.7M
Q1 24
$3.2M
$-79.6M
FCF Margin
CMT
CMT
PACB
PACB
Q4 25
-3.9%
-44.6%
Q3 25
-0.6%
-48.9%
Q2 25
1.1%
-75.3%
Q1 25
7.0%
-122.3%
Q4 24
0.8%
-82.3%
Q3 24
9.6%
-115.7%
Q2 24
14.6%
-154.8%
Q1 24
4.1%
-205.0%
Capex Intensity
CMT
CMT
PACB
PACB
Q4 25
10.7%
1.9%
Q3 25
8.4%
0.2%
Q2 25
3.3%
1.4%
Q1 25
2.9%
3.7%
Q4 24
7.2%
4.1%
Q3 24
3.1%
2.0%
Q2 24
3.3%
4.1%
Q1 24
2.4%
10.0%
Cash Conversion
CMT
CMT
PACB
PACB
Q4 25
Q3 25
2.44×
Q2 25
0.86×
Q1 25
2.79×
Q4 24
-12.93×
Q3 24
2.92×
Q2 24
2.47×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMT
CMT

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons